Abstract
Introduction
The clinical diagnosis of frontotemporal lobar degeneration (FTLD) in the early stages remains challenging. Although biomarkers from neuroimaging studies such as magnetic resonance imaging [1] and positron emission tomography [2] or from cerebrospinal fluid such as
Neuropsychological Assessment
The neuropsychological test battery performed at the ADRC included the Mini-Mental State Examination (MMSE) [17] , the Selective Reminding Test (SRT) [18] , the Boston Naming Test, short 15-item version (BNT-15) [19] , verbal fluency tests of initial letter and category [20] , the Rosen Drawing Test, 5-item version (RDT-5) [21] and the Digit Span subtest from the Wechsler Memory Scale Revised [22] . Orientation was assessed by 10 items about time and place from the MMSE. SRT sub-measures included short-term recall (SRT-STR), long-term retrieval (SRT-LTR), delayed free recall (SRT-DR) and delayed recognition (SRTDRcg). An SRT retention score (=delayed recall number/correct retrieval number at last trial of encoding phase) was also calculated. The Controlled Oral Word Association test included the letter verbal fluency test using C, F and L for English speakers and A, B and S for Spanish speakers (7 AD cases) [20] , and the semantic category fluency task used animal naming. The t scores of all neuropsychological tests were applied based on established age-and education-adjusted norms [23, 24] .
Neuropathological Evaluation
Neuropathological assessment was performed using a protocol described by Vonsattel et al. [25, 26] . Neuritic plaques and neurofibrillary tangles were detected using hematoxylin-eosin and the modified Bielschowsky silver method. Immunohistochemistry was performed for beta amyloid, phosphorylated tau, ubiquitin (p62), TDP-43 and glial fibrillary acidic protein. Autopsy-confirmed AD patients have been previously described [27] . Briefly, all of the AD cases met the criteria of Braak stage ≥ 4 neurofibrillary pathological findings and also met the CERAD neuropathological criteria for definite AD. The neuropathological diagnosis of FTLD-tau was based on the presence of tau-positive inclusions: Pick body (Pick disease), tau-positive tufted astrocytes (progressive supranuclear palsy) and ballooned achromatic neurons and astrocytic plaques (corticobasal degeneration). The neuropathological diagnosis of FTLD-U was based on the presence of typical TDP-43-type cytoplasmic ubiquitinated inclusions. Cases with FTLD did not demonstrate significant AD pathology (Braak stage ≤ 3 and NIA-Reagan criteria low likelihood).
Statistical Analyses
Baseline characteristics were compared among the groups using Pearson's χ 2 test or Fisher's exact test for nominal data. For continuous variables, Mann-Whitney test and Kruskal-Wallis test were used to assess differences between AD and FTLD (FTLD-tau + FTLD-U), and differences among AD, FTLD-tau and FTLD-U, respectively. To identify the underlying factor structure, a factor analysis was performed on 11 neuropsychological variables using the generalized least squares method with Promax rotation. Factor extraction was based on the Kaiser-Guttman rule of retaining components with eigenvalues >1. Factor loading of each test >0.35 was considered as a significant contributor to the factor. Mann-Whitney test and Kruskal-Wallis test were applied to each factor score and the age-and education-adjusted t values of each neuropsychological test to examine the differences between AD and FTLD, and the differences among AD, FTLD-tau and FTLD-U, respectively.
To assess the relative impairments in letter fluency compared to category fluency in FTLD, paired t tests after repeated measures analysis of variance were applied under the test condition (Letter Fluency or Category Fluency). An unpaired t test was used to compare the result of each fluency test between AD and FTLD. The 'semantic index score' [semantic index = Category Fluency/(Category Fluency + Letter Fluency)] was calculated as suggested by Rascovsky et al. [28] .
The contribution of each neuropsychological variable to the distinction between autopsy-confirmed AD and FTLD was examined by selecting age-and education-adjusted t values of 11 neuropsychological variables with p < 0.05 in the univariate analysis and included them simultaneously in a multiple logistic regression analysis using a forward selection method. To identify independent predictors for differentiation of FTLD-U from AD, for differentiation of FTLD-tau from AD and for differentiation of FTLD-U from FTLD-tau, separate logistic regression analyses were performed. Analyses were conducted using SPSS version 19 (IBM Corporation, New York, N.Y., USA) and statistical significance was defined as p = 0.05.
Results

Comparison of Clinical Features
Demographic data is shown in table 1 . The FTLD group was younger than the AD group at onset, initial visit and death. Subgroup analysis revealed that both the FTLD-tau and the FTLD-U group showed younger age of onset compared with the AD group. Time between onset of symptoms and death was shorter in patients with FTLD-U compared to patients with AD. The FTLD group showed an increased frequency of extrapyramidal tract signs at initial presentation compared with the AD group (Fisher's exact test; p < 0.001; table 1 ). Subgroup analysis showed a higher rate of extrapyramidal tract signs in both the FTLD-tau and the FTLD-U group compared with the AD group (Fisher's exact test; p = 0.001, post hoc analysis; p = 0.011 and p = 0.001, respectively). There were no group differences with regard to other symptoms, including depression.
The retrospective review of clinical data of all FTLD patients showed that all of the Pick patients presented with behavioral or personality changes, whereas patients with corticobasal degeneration, progressive supranuclear palsy and FTLD-U presented with heterogeneous cognitive symptoms such as language dysfunction, memory disturbance and depression, as well as motor symptoms in some cases (online suppl. table 1, see www. karger.com/doi/10.1159/000353860). Abnormalities in expressive language function were present in 5/11 (45.5%) FTLD-tau and in 6/13 (46.2%) FTLD-U patients. No patients presented with clinical features of semantic dementia. Motor neuron disease findings were ultimately present in 12/13 (92.3%) FTLD-U patients, but only 3 patients initially presented with such findings.
Neuropsychological Testing Domains Using Factor Analysis
The explanatory factor analysis solutions with the t values of all 11 neuropsychological tests revealed a factor structure consisting of three distinctive factors. The loadings from the rotated solution are shown in table 2 (upper part; rotated eigenvalues = 2.69, 2.35 and 1.89, respectively). The three factors were representative of memory, language and attention domain, according to the neuropsychological subscores from which high factor loadings were extracted. The correlation between memory factor and language factor was 0.300 and the correlation between language and attention factor was 0.436. However, the correlation between memory factor and attention factor was not significant ( table 2 , lower part). Table 3 (upper part) shows that the memory factor score in the AD group was lower than that in the FTLD group (p = 0.024), whereas the language factor and attention factor scores in the FTLD group were lower than those in the AD group (p = 0.002 and p = 0.015, respectively). Subgroup analysis demonstrated that language and attention factor scores in the FTLD-U group were significantly lower than in the AD group (p = 0.006 and p = 0.005, respectively). 
Comparison of Neuropsychological Testing
As shown in table 3 (lower part), the FTLD group showed, in comparison to the AD group, significantly lower scores on Digit Span Backward (p = 0.031), Letter Fluency (p < 0.001) and RDT-5 (p = 0.036) tests, but higher scores on SRT-DR (p = 0.002) and Orientation (p = 0.013). In the subgroup analysis, the FTLD-U group showed higher scores on SRT-DR (p = 0.011) and Orientation (p = 0.005), and lower scores on Digit Span Backward (p = 0.007), SRT-STR (p = 0.006) and Letter Fluency (p < 0.001) compared with AD patients. The FTLD-tau group's scores on RDT-5 and Letter Fluency were lower than those of the AD group (p = 0.010 and p = 0.006, respectively).
The memory retention score (=delayed recall number/correct retrieval number at last trial of encoding phase) was lower in the AD patients fig. 1 c) . Subgroup analysis showed that the semantic index in AD patients (mean = 0.49, SD = 0.14) was significantly lower than that in FTLD-U patients (mean = 0.64, SD = 0.12) (p = 0.002) ( fig. 1 d) .
Predictive Value of Neuropsychological Tests
Logistic regression analysis using a stepwise forward selection method showed that the SRT-DR (p < 0.001, OR = 1.179, 95% CI = 1.095-1.269), the BNT-15 (p = 0.020, OR = 0.966, 95% CI = 0.939-0.995) and Letter Fluency (p < 0.001, OR = 0.881, 95% CI = 0.823-0.943) remained as independent predictors of FTLD compared to AD in the final model. With this model, the diagnostic sensitivity for FTLD was 64.0%, while specificity was 95.5% and accuracy 88.6%. Separate logistic regression analyses showed that SRT-DR and Letter Fluency remained as independent predictors of FTLD-U compared to AD (sensitivity 58.3%, specificity 98.9%, accuracy 94.1%), and also showed that RDT-5, SRT-STR, SRT-DR and Letter Fluency remained as independent predictors of FTLD-tau compared to AD (sensitivity 46.2%, specificity 98.9%, accuracy 92.2%). Although RDT-5 and SRT-STR remained as independent predictors of FTLD-U compared to FTLD-tau in the final model, they did not reach statistical significance (p = 0.063 and p = 0.054, respectively; table 4 ). 
Discussion
We compared neuropsychological features at initial presentation in patients with early stages of dementia (CDR ≤ 1) eventually confirmed by autopsy as having suffered from FTLD or AD. Some prior studies have indicated that the neuropsychological characteristics of FTLD include early changes in verbal fluency, planning, working memory and executive function, in comparison to the more significant deficits in episodic memory, visuospatial function and praxes characteristic of AD [6, [29] [30] [31] . However, other studies have failed to find such differences between AD and FTLD [5, [32] [33] [34] . These discrepancies may relate to different neuropsychological measures used, small sample sizes, difficulties with clinical classification and heterogeneity of FTLD. To elucidate the validity of neuropsychological testing in differentiating FTLD from AD, we restricted our analysis to subjects with early stages of disease (CDR ≤ 1) and examined the results using factor analysis of neuropsychological test scores, as well as examining components of memory testing.
Factor analysis showed three latent factors: memory, language and attention. Comparison of the factor scores showed dissociative patterns, with the FTLD patients performing better on the memory factor and worse on the language and attention factors compared with the AD patients. Factor analysis allows us to reduce a large amount of complicated data of neuropsychological scores, to evaluate the construct validity of a test battery adopted, and to reveal the cognitive background of the diseases [35, 36] . Therefore, data reduction using factor analysis and investigating affected cognitive domains would be useful for discriminating between diseases whose neuropsychological manifestations mimic each other.
Memory test sub-measures were useful in discriminating FTLD from AD. FTLD patients showed preserved memory retention compared with AD patients, although the other submeasures of SRT such as long-term retrieval and delayed recognition in FTLD patients were comparable to those in AD patients. Examining FTLD-U and FTLD-tau separately, short-term recall only in FTLD-U was significantly lower than in AD. Considering three aspects of episodic long-term memory, including encoding, storage and retrieval, SRT sub-measures allow assessment of working memory by short-term recall, memory encoding by long-term retrieval, and memory retrieval by delayed recall [18] . Our results suggest that FTLD patients show preserved abilities in the memory storage and retrieval phases compared with AD patients, whereas FTLD patients, especially FTLD-U patients, show more deficits in working memory. Prior studies have been inconsistent in this regard, with some reporting that the memory disturbance of FTLD is similar to that of AD [37] , while others have reported differences between FTLD and AD for encoding and forgetting rate in word list memory tests [38] . Memory disturbance in FTLD may result from frontal-executive impairments such as inefficient memory strategies and working memory rather than storage or recall deficits themselves [39] or impaired access to semantic representations [40] . This contrasts with memory impairment in AD, which likely relates principally to encoding impairment due to entorhinal cortex and hippocampus dysfunction present at the earliest stages of the disease [41] . These pathological differences are likely responsible for the difference in memory sub-measures between the groups, which may allow better differentiation of FTLD from AD.
Verbal fluency tests also allowed some distinction between FTLD and AD. Our results showed that both types of verbal fluency in FTLD were more affected than in AD. However, Letter Fluency was more impaired than Category Fluency in FTLD compared with AD. Prior studies have also shown that Letter Fluency may be more impaired than Category Fluency in FTLD compared with AD [42, 43] . Rascovsky et al. [28] have shown disparate phonemic letter fluency and semantic category fluency deficits in autopsy-confirmed FTLD. Semantic fluency likely depends on the integrity of semantic memory, which demands the temporal-lobemediated semantic system, whereas phonemic fluency may be more sensitive to executive dysfunction, which may be caused by frontal lobe damage [44] . Thus, the differences in performance on these tasks are consistent with differing principal pathological involvement between AD with early temporal involvement and FTLD with early frontal involvement.
Discriminant analysis for FTLD versus AD using logistic regression showed that Letter Fluency, the BNT-15 and the SRT-DR were independent predictors of FTLD pathology. Although cut-off points in our study did not allow sufficient discrimination of the two groups, it is possible that combinations of certain tests measuring specific cognitive domains, such as language function and memory, might be useful to discriminate FTLD from AD. Similarly, while we were able to discriminate between FTLD-U and AD as well as between FTLD-tau and AD, we were unable to successfully discriminate between FTLD-U and FTLD-tau using logistic regression analysis. This may be related to the tests used or to an overlap between the impairments in these subgroups. Prior work has included some reporting differences between FTLD-tau and FTLD-U/TDP [8, 10] , some failing to find such neuropsychological differences [11] . It may be necessary to incorporate measures of behavioral change, neuropsychiatric symptoms, concomitant neurological signs and neuroimaging data to make such distinctions between different FTLD pathologies.
There are several limitations to the present study. One is the selection of the neuropsychological battery. A more detailed evaluation of specific areas of function may better characterize the differences between patients with AD and FTLD. Frontal lobe functions such as executive function, judgment and personality have been particularly implicated in FTLD [6] , and our battery had only limited tests with respect to these functions. Secondly, this sample was not population-based but clinic-based, and the sample size of the FTLD group was small, therefore the results may not be generalizable. Thirdly, not every case had TDP-43 staining, so heterogeneity of the FTLD-U cases is possible. Finally, we do not have sufficient longitudinal data to determine whether rate of change measures might be more useful [31] .
Conclusions
Our study suggests the following: (1) FTLD patients at early symptomatic stages show lower test scores in attentional and language domains and higher test scores in memory domain than do AD patients. (2) FTLD patients show a pattern of memory subtest findings suggesting working memory deficits, whereas AD patients show delayed recall deficits. (3) FTLD patients show more impaired Letter Fluency than Category Fluency, unlike AD patients. (4) FTLD can possibly be discriminated from AD using combined test scores of Letter Fluency, the Boston Naming Test and delayed recall. (5) FTLD-U and FTLD-tau patients are not distinguishable by their neuropsychological test performances.
